CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $945,674 | +0.4% | 34,710 | -18.0% | 0.09% | +1.2% |
| Q2 2023 | $942,288 | +9.3% | 42,350 | +6.4% | 0.09% | +1.2% |
| Q1 2023 | $862,068 | +6.6% | 39,800 | 0.0% | 0.08% | -2.3% |
| Q4 2022 | $808,338 | -20.8% | 39,800 | 0.0% | 0.09% | -27.5% |
| Q3 2022 | $1,020,000 | +7.8% | 39,800 | 0.0% | 0.12% | +15.4% |
| Q2 2022 | $946,000 | +5.6% | 39,800 | 0.0% | 0.10% | +19.5% |
| Q1 2022 | $896,000 | +13.7% | 39,800 | 0.0% | 0.09% | +24.3% |
| Q4 2021 | $788,000 | -11.0% | 39,800 | 0.0% | 0.07% | -23.1% |
| Q3 2021 | $885,000 | +1.0% | 39,800 | 0.0% | 0.09% | 0.0% |
| Q2 2021 | $876,000 | -7.5% | 39,800 | 0.0% | 0.09% | -35.0% |
| Q1 2021 | $947,000 | -9.0% | 39,800 | 0.0% | 0.14% | -15.7% |
| Q4 2020 | $1,041,000 | +50.2% | 39,800 | 0.0% | 0.17% | +32.8% |
| Q3 2020 | $693,000 | +3.6% | 39,800 | 0.0% | 0.12% | -6.0% |
| Q2 2020 | $669,000 | +41.4% | 39,800 | 0.0% | 0.13% | +17.7% |
| Q1 2020 | $473,000 | -1.9% | 39,800 | 0.0% | 0.11% | +18.9% |
| Q4 2019 | $482,000 | -14.4% | 39,800 | 0.0% | 0.10% | -18.1% |
| Q3 2019 | $563,000 | +26.8% | 39,800 | 0.0% | 0.12% | +28.9% |
| Q2 2019 | $444,000 | -4.9% | 39,800 | 0.0% | 0.09% | -6.2% |
| Q1 2019 | $467,000 | -12.2% | 39,800 | 0.0% | 0.10% | -21.3% |
| Q4 2018 | $532,000 | -4.7% | 39,800 | 0.0% | 0.12% | +8.0% |
| Q3 2018 | $558,000 | -10.9% | 39,800 | 0.0% | 0.11% | -8.9% |
| Q2 2018 | $626,000 | -4.4% | 39,800 | 0.0% | 0.12% | -8.1% |
| Q1 2018 | $655,000 | -8.9% | 39,800 | 0.0% | 0.14% | -7.5% |
| Q4 2017 | $719,000 | -6.4% | 39,800 | 0.0% | 0.15% | -11.0% |
| Q3 2017 | $768,000 | +63.4% | 39,800 | 0.0% | 0.16% | +51.9% |
| Q2 2017 | $470,000 | +7.8% | 39,800 | 0.0% | 0.11% | 0.0% |
| Q1 2017 | $436,000 | +50.9% | 39,800 | 0.0% | 0.11% | +35.0% |
| Q4 2016 | $289,000 | +95.3% | 39,800 | +74.6% | 0.08% | +90.5% |
| Q3 2016 | $148,000 | +19.4% | 22,800 | 0.0% | 0.04% | +13.5% |
| Q2 2016 | $124,000 | +15.9% | 22,800 | 0.0% | 0.04% | 0.0% |
| Q1 2016 | $107,000 | – | 22,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |